ANVRX
Price
$10.95
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
551.01M
VIHAX
Price
$48.62
Change
+$0.31 (+0.64%)
Updated
Jun 2 closing price
Net Assets
19.99B
Interact to see
Advertisement

ANVRX vs VIHAX

Header iconANVRX vs VIHAX Comparison
Open Charts ANVRX vs VIHAXBanner chart's image
ANVRX vs VIHAX Comparison Chart in %
View a ticker or compare two or three
VS
ANVRX vs. VIHAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVRX is a Hold and VIHAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIHAX has more cash in the bank: 20B vs. ANVRX (551M). VIHAX pays higher dividends than ANVRX: VIHAX (3.40) vs ANVRX (3.06). ANVRX was incepted earlier than VIHAX: ANVRX (7 years) vs VIHAX (10 years). ANVRX (1.68) is less costly to investors than VIHAX (0.16). ANVRX is a more actively managed with annual turnover of: 71.00 vs. VIHAX (9.00). ANVRX has a lower initial minimum investment than VIHAX: ANVRX (2500) vs VIHAX (3000). VIHAX annual gain was more profitable for investors over the last year : 26.29 vs. ANVRX (16.33). VIHAX return over 5 years is better than : 50.19 vs. ANVRX (14.75).
ANVRXVIHAXANVRX / VIHAX
Total Expense Ratio1.680.161,050%
Annual Report Gross Expense Ratio1.680.161,050%
Fund Existence7 years10 years-
Gain YTD7.14311.25063%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets551M20B3%
Annual Yield % from dividends3.063.4090%
Returns for 1 year16.3326.2962%
Returns for 3 years22.0964.4834%
Returns for 5 years14.7550.1929%
Returns for 10 yearsN/A102.41-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TMP86.090.94
+1.10%
Tompkins Financial Corp
ITUB7.860.07
+0.94%
Itau Unibanco Banco Holding SA
QS9.200.06
+0.66%
QuantumScape Corp
ASPC11.05-0.01
-0.05%
A Spac III Acquisition Corp
CNTX2.42-0.37
-13.26%
Context Therapeutics